8-K
Current Report
Vanda Pharmaceuticals Inc. Filed Acc 0000950133-08-004078
Exit or restructuring costs · Executive or director change · Bylaws or fiscal year change
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading w72005e8vk.htm…